AI assistant
Sending…
ABBOTT LABORATORIES — Director's Dealing 2015
Aug 20, 2015
29777_dirs_2015-08-20_2a1898a6-1109-4545-b5a4-03a4cf36722f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2015-06-01
Reporting Person: Ford Robert B (Executive Vice President)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-06-01 | Option (right to buy) | $48.90 | A | 14243 | Acquired | 2025-05-31 | Common shares (14243) | Direct |
Footnotes
F1: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 4,748 on 6/1/2016, 4,747 on 6/1/2017, and 4,748 on 6/1/2018.
F2: This Form 4/A amends the number of derivative securities acquired on June 1, 2015.
More from ABBOTT LABORATORIES
Regulatory Filings
2026
May 27
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 24
Legal Proceedings Report
2026
Apr 17
Earnings Release
2026
Apr 16
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 25